The first female meiotic division (meiosis I, MI) is uniquely prone to chromosome segregation errors through nondisjunction, resulting in trisomies and early pregnancy loss 1 . Here, we show a fundamental difference in the control of mammalian meiosis that may underlie such susceptibility. It involves a reversal in the well-established timing of activation of the anaphase-promoting complex (APC) 2,3 by its co-activators cdc20 and cdh1. APC cdh1 was active first, during prometaphase I, and was needed in order to allow homologue congression, as loss of cdh1 speeded up MI, leading to premature chromosome segregation and a non-disjunction phenotype. APC cdh1 targeted cdc20 for degradation, but did not target securin or cyclin B1. These were degraded later in MI through APC cdc20 , making cdc20 re-synthesis essential for successful meiotic progression. The switch from APC cdh1 to APC cdc20 activity was controlled by increasing CDK1 and cdh1 loss. These findings demonstrate a fundamentally different mechanism of control for the first meiotic division in mammalian oocytes that is not observed in meioses of other species.
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The E3 ligase activity of the anaphase-promoting complex (APC) that is bound to its co-activator cdh1 (APC cdh1 ) is commonly associated with late M phase and early G1 phase of the cell cycle, where it contributes to M-phase exit by degradation of mitotic proteins, while simultaneously preventing precocious DNA replication [3] [4] [5] [6] . APC cdh1 activity is also observed in mouse oocytes at the germinal vesicle (GV) stage, equivalent to late G2, where it contributes to cyclin B1 degradation, thus being required for the maintenance of GV arrest 7, 8 . We wanted to establish whether or not cdh1 had any role in meiosis I (MI) after GV breakdown (GVB), independent of its role in maintaining GV arrest. Therefore, we examined the ability of oocytes to progress through MI following microinjection with a cdh1 antisense morpholino (cdh1 MO ). Culture in milrinone-containing medium for 24 h following cdh1 MO microinjection is sufficient to reduce cdh1 levels by >90% (hereafter known as 'cdh1-knockdown oocytes') but maintain GV arrest in the majority of oocytes, with longer-term culture (48 h) being needed to promote GVB 7 . In cdh1-knockdown oocytes, which maintained arrest over 24 h, we found that progression through MI was accelerated following milrinone washout. Oocytes extruded a polar body (PB), which forms on completion of MI, 1.5 h earlier than non-injected oocytes (Fig. 1a) . This effect was attributed specifically to loss of cdh1, as it was not observed in mock cdh1-depleted oocytes through addition of a 5-base-mismatch cdh1 morpholino (5MM-cdh1 MO ). The acceleration of PB could have been due to a loss in cdh1 during either GV arrest or MI. However, it was attributed specifically to a function in MI because we could restore normal PB timing by rescuing cdh1 expression after GVB. Thus, in cdh1-knockdown oocytes, cdh1 cRNA injection, which was made on release from milrinone (hereafter known as 'cdh1-rescue oocytes'), rescued a normal phenotype (Fig. 1a) .
The MI acceleration in cdh1-knockdown oocytes led to premature segregation and non-disjunction of homologues. Following oocyte maturation, chromatin in cdh1-knockdown oocytes often failed to fully align on a metaphase II spindle and was sometimes dispersed, suggesting that segregation of homologues had not occurred properly ( Fig. 1b ; see Supplementary Information, Fig. S1 ). To examine this further, chromosome spreads were performed in which the hyperploidy rate was calculated; this circumvented problems associated with chromosome loss during the fixing procedure 9 . About one-third of the cdh1-knockdown oocytes were hyperploid (Fig. 1b) , suggesting that non-disjunction had occurred in the majority of oocytes if one assumes that chromosome segregation was stochastic between the PB and oocyte. These effects were attributed to loss of cdh1, as both 5MM-cdh1 MO -injected oocytes and cdh1-rescue oocytes formed metaphase II spindles and were not hyperploid (Fig. 1b) . Live-cell chromatin imaging during maturation of uninjected and cdh1-knockdown oocytes confirmed the immunofluorescence and chromosome spread results. In control oocytes, chromosomes underwent condensation after GVB, congressed on a metaphase I plate, migrated to the oocyte cortex and underwent anaphase ( Fig. 1c ; see Supplementary Information, Movie 1). Condensed chromosomes in cdh1-knockdown oocytes, however, underwent anaphase without congression onto an obvious metaphase plate and so generated lagging chromosomes ( Fig. 1d ; see Supplementary Information, Movie 2).
We wanted to establish whether or not the acceleration of MI by cdh1 knockdown was associated with accelerated degradation of proteins that were known to be degraded at this time. At the mitotic metaphase-anaphase transition, both cyclin B1, the regulatory subunit of CDK1, and securin, which prevents loss of cohesin from attached sisters by inhibiting separase, are degraded simultaneously 10 . Loss of endogenous and fluorescent-protein-tagged cyclin B1 and securin during MI have been reported previously, but comparison of degradation in the same oocyte has not been performed 11, 12 . Therefore, we visualized cyclin B1 and securin degradation together in an oocyte by coupling to separable fluorescent proteins, and found simultaneous degradation (see Supplementary  Information, Fig. S2a ). When levels of cdh1 were knocked down, the initiation of both cyclin B1 (Fig. 2a,b) and securin (see Supplementary  Information, Fig. S2b ,S2c) were brought forward by about 1.5 h, a timing which is consistent with the accelerated PB extrusion observed above. This effect was specific for cdh1, as it was not observed for the control 5MM-cdh1 MO , and normal timing of cyclin B1 degradation was restored in cdh1-rescue oocytes. Although cdh1 was involved in the timing of cyclin B1 and securin degradation, it seemed not to contribute to actual degradation, as their rates of loss were unaffected by cdh1 knockdown (see Supplementary Information, Fig. S2d ). This indicates that cyclin B1 and securin are degraded through the same mechanism in MI, possibly by APC cdc20 activity, as in mitosis. Indeed, both cyclin B1 degradation (Fig. 2c,d ) and securin degradation (data not shown) were blocked by 
N o in j. addition of the spindle poison nocodazole or microinjection of cRNA to mad2, a component of the spindle assembly checkpoint (SAC) pathway, which is a well-established means of inhibiting APC cdc20 in mitosis 3 . This was the case in control oocytes with unperturbed levels of cdh1 (Fig. 2c) , and in cdh1-knockdown oocytes (Fig. 2d) , suggesting that loss of cdh1 does not accelerate MI by overriding any SAC-imposed arrest.
The acceleration of MI and the resulting non-disjunction observed following cdh1 knockdown suggested that prometaphase APC cdh1 may delay homologue segregation to allow full congression on a metaphase plate. To demonstrate APC cdh1 activity directly during prometaphase I, we examined the degradation of its substrate cdc20 (refs 2, 3). Cdc20-GFP was used as a reporter for APC cdh1 activity but was itself biologically inactive, as it lacked the ability to rescue cdc20 knockdown (see Fig. 4b later). We attribute this to occlusion of the C-terminal IR tail, which is involved in APC binding 13 . However, cdc20-GFP proved to be a good reporter of APC cdh1 activity, as it was degraded in oocytes shortly after GVB in a period lasting 2-4 h ( Fig. 3a ; see Supplementary Information, Fig. S3a,b ). Degradation was due to cdh1, as it was blocked in cdh1-knockdown oocytes, not observed with control 5MM-cdh1 MO and was recovered in cdh1-rescue oocytes (Fig. 3a) . Interestingly, with respect to these fluorescent protein chimeras, the time of initiation for cdc20 degradation appeared to occur earlier than for either cyclin B1 or securin, despite all being APC cdh1 substrates. Therefore, to determine whether or not such timings were an artefact of overexpressed fluorescent protein chimeras, we analysed any changes in endogenous proteins levels in uninjected maturing oocytes. Importantly, we observed the same relative timing of endogenous cdc20, cyclin B1 and securin degradation as that for the chimeras (Fig. 3b) . Maximum cdc20 degradation was seen 3-4 h after GVB; at this time, both cyclin B1 and securin levels were still rising, with their degradation occurring 1-2 h later. Cdh1 knockdown resulted in stabilization of endogenous cdc20, and cdh1 rescue recovered this loss (Fig. 3c) . Therefore, with both fluorescent protein chimeras and endogenous proteins, we have observed APC cdh1 -mediated cdc20 degradation ahead of any loss in cyclin B1 and securin.
To demonstrate again that the degradation of cdc20 occurs ahead of cyclin B1, cyclin-B1-YFP and cdc20-CeFP (Cerulean fluorescent protein) cRNA were expressed in the same oocyte and their expression monitored during oocyte maturation. Cdc20 degradation preceded cyclin B1, in a period soon after GVB (Fig. 3d) . There was no observable loss in cyclin B1 at this time; its degradation began as the period of cdc20 degradation ended (Fig. 3d , and see Supplementary Information, Fig. S3c ). All these findings taken together show that, during MI, APC cdh1 has substrate preference for cdc20 over cyclin B1 and securin; this is the case for both endogenous protein and proteins expressed from cRNA. This may be explained by the manner in which these substrates are degraded -either processive or distributive ubiquitination -which underlies the temporal ordering of degradation for mitotic APC cdh1 substrates 14 . In addition, the binding of accessory factors to APC cdh1 during prometaphase I may either enhance the degradation of cdc20, or decrease that of cyclin B1 and securin at this time -a phenomenon that was previously observed for a number of APC cdh1 substrates [15] [16] [17] . When cdh1-knockdown oocytes were co-expressing cyclin-B1-YFP and cdc20-CeFP cRNA, no degradation of cdc20 was seen (Fig. 3d) , which is consistent with prometaphase APC cdh1 activity leading to loss of cdc20. However, cyclin-B1-YFP degradation proceeded at a normal rate, confirming that its degradation during MI is APC cdh1 -independent. Cdh1 knockdown, however, brought forward the time of cyclin B1 degradation to the point at which cdc20 would normally have been degraded (see Supplementary Information, Fig. S3c ). In fact, regardless of the actual time of onset for cdc20 degradation, cyclin B1 degradation followed 2 h later (see Supplementary Information, Fig. S3d ).
Cdc20 is essential for MI in lower eukaryotes but dispensable in frogs [18] [19] [20] [21] [22] . Therefore, we wanted to establish the cdc20 dependency of MI in mice. During maturation, cdc20 quickly re-accumulated after its loss, making it possible that nascent cdc20 was necessary for APC cdc20 -mediated cyclin B1 and securin loss. Protein synthesis was needed for MI completion, as cycloheximide added to oocytes at 4 h post-GVB -when cdc20 levels were low -blocked PB extrusion (control, 91% PB extrusion rates, n=34; with cycloheximide, 30% PB extrusion rates, n=37). We used a cdc20 morpholino (cdc20 MO ; MO + cdh1 cRNA (n = 14); or no further injections (no inj.; n = 22). Note that cdh1 knockdown prevented cdc20-GFP degradation between germinal vesicle breakdown (GVB) and polar body (PB) extrusion. (b, c) Western blot and densitometric analysis of endogenous cdc20, cyclin B1 and securin levels (50 per lane) at the times indicated relative to GVB (0 h is GV arrest). In b, oocytes were uninjected; note the early loss in cdc20 at 4 h, ahead of both cyclin B1 or securin. In c, oocytes were microinjected with cdh1 MO and cdh1 cRNA as indicated; note that cdh1 knockdown abolished cdc20 loss and brought forward cyclin B1 and securin degradation. Cdc20 degradation at 4 h was recovered by cdh1 cRNA rescue. Actin was used as a loading control. Blots are representative of two further replicates. K, relative molecular mass in thousands. (d) Cyclin-B1-YFP and cdc20-CeFP fluorescence levels recorded simultaneously during maturation, with or without microinjection of cdh1 MO as indicated. Representative traces (top, n = 40; bottom, n = 44) of cyclin-B1-YFP and cdc20-CeFP fluorescence during maturation. In a and d, the timing of GVB and PB extrusion are marked by arrowheads. (b, c) Uncropped western blots for cdc20, securin and cyclin B1 are displayed in the Supplementary Information, Fig. S4 . nature cell biology volume9|number10|oCTober2007hereafter known as 'cdc20 knockdown') to block cdc20 re-accumulation during MI (Fig. 4a) , and therefore examine directly the role played by cdc20 protein synthesis in MI. Cdc20 knockdown specifically blocked PB extrusion (Fig. 4b) , as it was not observed with a 5-base mismatch morpholino (5MM-cdc20 MO ) and high rates of PB extrusion could be restored by cdc20 cRNA microinjection (Fig. 4a,b ; hereafter known as 'cdc20 rescue'). These data suggest that cdc20 re-accumulation during MI was needed for securin and cyclin B1 degradation. To examine this directly, we measured the rate of degradation of both cyclin B1 (Fig. 4c) and securin (see Supplementary  Information, Fig. S2e ) and found them to be substantially reduced following cdc20 knockdown. This was not due to the microinjection procedure because normal rates of cyclin B1 degradation were observed following 5MM-cdc20 MO microinjection (Fig. 4c) . These data show that re-accumulation of cdc20 was needed for completion of MI and that, in an unperturbed MI, APC cdc20 contributed to cyclin B1 and securin degradation. In cdh1-knockdown oocytes, cdc20 was also responsible for cyclin B1 and securin degradation. We could not knockdown cdc20 in a cdh1 knockdown background because cdc20 loss was dependent on APC cdh1 ; however, large injections of cdc20-CeFP (4-fold greater pipette concentration than used elsewhere), acted as a dominant-negative construct to block PB extrusion and inhibit cyclin B1 degradation in cdh1-knockdown oocytes (Fig. 4d) .
These data, along with the observed ability of mad2 to block degradation (Fig. 2d) , strongly suggest that APC cdc20 is responsible for cyclin B1 and securin degradation in cdh1-knockdown oocytes.
Although CDK1 can phosphorylate and so inhibit cdh1 binding to the APC 23, 24 , its rise in oocytes during prometaphase I was found to be sufficiently slow to allow APC cdh1 to function. ∆90cyclin B1 cRNA, which accelerated CDK1 activity (Fig. 5a ) and increased phosphorylated cdh1 (Fig. 5b, phosphorylated cdh1 migrates more slowly 23 ), reduced the period of APC cdh1 -mediated cdc20 degradation by about 50% (Fig. 5d,e) . During oocyte maturation, we also observed a loss of endogenous cdh1 6-7 h after GVB (Fig. 5c ). This loss in cdh1, which can be degraded through both APC-and SCF-dependent mechanisms 25, 26 , suggested that the switch from APC cdh1 to APC cdc20 activity could be regulated by both CDK1 activity and cdh1 degradation. In fact, they appeared to act redundantly in switching off APC cdh1 , because it was only when both cdh1 cRNA was overexpressed and CDK1 inhibited, that the period over which APC cdh1 was active increased (Fig. 5e ). In summary, we have shown that, in prometaphase, APC cdh1 is active and has a role to play in oocyte maturation, slowing the passage through MI and allowing time for homologues to congress. APC cdh1 activity preferentially targeted cdc20 for degradation over cyclin B1 and securin, the later degradation of which was mediated by cdc20. Cdc20 resynthesis was therefore essential for the completion of MI. Cdh1 
-test).
In c and d, the range over which PB extrusion occurred is as marked.
knockdown moved forward the period of APC cdc20 activity despite a lack of homologue congression, indicating that the various SAC components in oocytes 9, 27, 28 do not act to monitor bivalent orientation -a finding demonstrated previously in studies in mice carrying a univalent X chromosome 29 . The present work therefore describes a mechanism that controls the timing of mammalian meiosis, which has not been observed for other cell divisions.
METHODS
Oocyte collection and culture. GV oocytes were collected from 4-6-week-old MFI mice (Harlan, Bicester, UK) 44-52 h after intraperitoneal injection of 7.5 IU pregnant mares' serum gonadotrophin (Calbiochem, Nottingham, UK). For bench handling, microinjections and imaging experiments, oocytes were cultured in medium M2 following the mechanical removal of granulosa cells. For long-term incubation, oocytes were cultured in MEM (22571-020; Gibco, Paisley, UK) with 20% foetal calf serum in a 5% CO 2 humidified incubator at 37 °C. Milrinone (1 μM; Sigma-Aldrich, Poole, UK) was used to arrest GV oocytes. Chromosome spreads and H1 kinase assays on oocytes were performed as described previously 7, 30 . cRNA and morpholinos. Cdc20, cdh1, cyclin B1, ∆90cyclin B1 and mad2 cRNA were made as described previously 7, 31 , using a modified pRN3 vector designed to produce protein C-terminally coupled to CFP (Cyan), CeFP (Cerulean), GFP (Green), Venus (Yellow), YFP (Yellow) or unlabelled. cRNA was synthesized using T3 mMESSAGE mMACHINE (Ambion, Huntingdon, UK), and dissolved in nuclease-free water to a concentration of approximately 1 µg µl 
For all experiments involving cdc20
MO or 5MM-cdc20 MO , oocytes were microinjected in milrinone-arresting medium, then washed free of milrinone following completion of microinjection.
Microinjections and imaging.
All microinjections into oocytes were made on the heated stage of a Nikon TE300 inverted microscope as described previously 7 . Briefly, micropipettes were inserted into cells using the negative capacitance overcompensation facility on an electrophysiological amplifier. A single 0.1-0.3% volume injection was achieved using a timed injection on a Pneumatic PicoPump (World Precision Instruments, Stevenage, UK). Bright-field and epi-fluorescence images were recorded using a Sony Interline MicroMax CCD camera. Confocal sections were performed on a Leica SP2. Metamorph and Metafluor software (Universal Imaging Corp., Downington, PA) were used for image capture and data analysis.
Immunoblotting. Western blotting was performed as described previously 7 using antibodies against cdc20 (sc-8358; Santa Cruz Biotechnology Inc., Santa Cruz, CA) at 1:200; cdh1 (ab3242; Abcam, Cambridge, UK) at 1:200; securin (ab3305; Abcam) at 1:1000,; cyclin B1 (ab72; Abcam) at 1:400; and actin (ab3280; Abcam) at 1:400. Blots were incubated in primary antibodies overnight at 4 ºC, using nonfat milk (5%) as a blocking agent. Anti-rabbit IgG (for polyclonals; P0448; Dako, Ely, UK), anti-mouse IgG (for monoclonals; P0447; Dako) and ECL Plus (RPN2132; GE Healthcare; Little Chalfont, UK) were used as secondary detection reagents according to the manufacturer's instructions.
Immunofluorescence microscopy. Oocytes were fixed with 3.7% paraformaldehyde in phosphate-buffered saline (PBS) containing 1% polyvinylpyrrolidine (PBS+PVP) and then transferred to the same containing 2% Triton X-100. Fixing and permeabilizing were for 30 min each at room temperature. Oocytes were then washed extensively in PBS+PVP before incubation with 1:400 anti-tubulin (ab6160; Abcam). Following further washes, oocytes were incubated with 1:20 TRITC-labelled rabbit anti-mouse IgG (Dako) and Hoechst 33258 to stain chromatin. These incubations were at 37 °C in PBS+PVP. . (a) H1 kinase assays of maturing oocytes at the times indicated, normalized with respect to time 0 h (germinal vesicle (GV) arrest). Some GV oocytes were microinjected with ∆90cyclin B1 cRNA (∆90cycB1) before maturation (n = 5). ∆90cyclin B1 increased the rate of rise of H1 kinase activity following GV breakdown (GVB). (b, c) cdh1 expression in oocytes at the times indicated after GVB. In b, cdh1 MO , or cRNA for ∆90cyclin B1 and cdh1, were microinjected as indicated. K, relative molecular mass in thousands. (d) cdc20-GFP fluorescence changes in a control (black) and ∆90cyclin B1 cRNA-injected oocytes (grey), plotted with respect to time as a percentage of the maximum recorded fluorescence before any cdc20 loss. Time t is the time taken to reach the minimum recorded fluorescence from the start of cdc20 degradation and is plotted in e. (e) The period of cdc20-GFP degradation (t), calculated from experiments performed as in part d, in oocytes injected with cRNA for ∆90cyclin B1 and cdh1 or treated with roscovitine (ROS). Numbers examined are in parentheses, with oocytes being pooled for each condition from at least two independent experiments. In a and e, error bars are SD and asterisks mark time points that are significantly different from: time 0 (a) or no additions (e) (P < 0.05, ANOVA).
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